National Institute for Health and Clinical Excellence (NICE)
This recommendation is not intended to affect treatment with tocilizumab that was started in the NHS before this guidance was published. People having treatment outside this recommendation may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS clinician consider it appropriate to stop.
Giant cell arteritis is usually treated with a high dose of glucocorticoids, which is gradually reduced over time. High doses of ...
National Institute for Health and Clinical Excellence (NICE)
This recommendation is not intended to affect treatment with padeliporfin that was started in the NHS before this guidance was published. People having treatment outside this recommendation may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS clinician consider it appropriate to stop.
Current treatments for low-risk prostate cancer include active surveillance and, for people whose disease has progressed (usually ...
National Institute for Health and Clinical Excellence (NICE)
This recommendation is not intended to affect treatment with lesinurad that was started in the NHS before this guidance was published. People having treatment outside this recommendation may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS clinician consider it appropriate to stop.
Drug treatments for gout include 2 xanthine oxidase inhibitors, allopurinol or, if that is not tolerated, febuxostat. Evidence from 2 ...
National Institute for Health and Clinical Excellence (NICE)
Make sure the person with oesophago-gastric cancer is given information, in a format that is appropriate for them, to take away and review in their own time after you have spoken to them about their cancer and care.
Inform people with oesophago-gastric cancer about peer-to-peer local or national support groups for them to join if they wish.
National Institute for Health and Clinical Excellence (NICE)
Clinicians wishing to do nerve transfer to partially restore upper limb function in tetraplegia should:
- Inform the clinical governance leads in their NHS trusts.
- Ensure that patients understand the uncertainty about the procedure's safety and efficacy, and provide them with clear written information to support shared decision-making. In addition, the use of NICE's information for the public is recommended.
- Audit and review clinical outcomes of all patients having nerve transfer to ...